Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Neuren Pharmaceuticals (ASX: NEU) is a biopharmaceutical company developing novel therapeutics in the fields of neural repair and rescue and metabolic disorders. The Neuren portfolio consists of six product families, targeting markets with large unmet needs and limited competition. Neuren has two lead clinical candidates, Glypromate® and NNZ-2566, presently in development to treat a range of acute neurological conditions. Neuren has commercial and development partnerships, including with Pfizer, the US Army’s Walter Reed Army Institute of Research and Metabolic Pharmaceuticals. ( www.neurenpharma.com )
Neuren Pharmaceuticals Limited
Level 13 122 Arthur St
North Sydney, New South Wales 2060
Australia
Tel: +64 9 529 3940
Fax: +64 9 529 3941